retacrit.com
#9,310,974
Global Rankeez rank — last updated 01 Sep 2026
Better than 90.7% of the 100,511,422 domains we track
Best rank recorded
#9,310,974
2026-09
Worst rank recorded
#12,894,521
2026-08
Tracked since
2026-07
5 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how retacrit.com scores in each:
| Source | Rank |
|---|---|
| DomCop / OpenPageRank | #9,558,747 |
| CommonCrawl (hyperlink graph) | #12,227,568 |
See how these sources are combined and cross-validated →
Ranking history
retacrit.com's rank across 5 monthly snapshots. ▲ improved by 1,996,436 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #11,307,410 |
| 2026-08 | #12,894,521 |
| 2026-09 | #9,310,974 |
| 2026-10 | #9,312,765 |
| 2026-11 | #9,310,974 |
JSON API
{
"retacrit.com": 9310974,
"history": {
"2026-07": 11307410,
"2026-08": 12894521,
"2026-09": 9310974,
"2026-10": 9312765,
"2026-11": 9310974
}
}
GET https://rankeez.com/api/retacrit.com.json · see API docs →
More about retacrit.com
retacrit.com — page content & similar sites →
See risks & benefits. Find RETACRIT (epoetin alfa-epbx), the first FDA-approvedESA biosimilar to Epogen (epoetin alfa) & Procrit (epoetin alfa) in the US.
retacrit.com — full site profile →
WHOIS, tech stack and extended traffic history for retacrit.com.